Back to search
FDAFDA · Food and drugs·Recall number D-150-2013

Carisoprodol Tablets, USP, 350 mg, packaged in a) 500-count tablets per bottle (NDC 0143-1176-05) and b) 1000-count tablets per bottle (NDC 0143-1176-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Published February 13, 2013 · Recall initiated: December 7, 2012

Summary

FDA records drug Class II recall D-150-2013, published February 13, 2013 and initiated December 7, 2012. Recalling firm: West-ward Pharmaceutical Corp.; Status: Terminated; Reported quantity: 8,585 bottles; Lot: Lot #: 69364A, 69365A, and 69365B, Exp 10/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: Uncharacteristic blacks spots on tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
West-ward Pharmaceutical Corp.
Distributor
Nationwide
Lot
Lot #: 69364A, 69365A, and 69365B, Exp 10/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carisoprodol Tablets, USP, 350 mg, packaged in a) 500-count tablets per bottle (NDC 0143-1176-05) and b) 1000-count tablets per bottle (NDC 0143-1176-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724. recalled?

Yes. FDA published recall D-150-2013 on February 13, 2013. Reported hazard: Presence of Foreign Substance: Uncharacteristic blacks spots on tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter